PTP-MEG Antibodies

Santa Cruz Biotechnology features a diverse variety of PTP-MEG monoclonal antibodies for research focused on understanding protein tyrosine phosphatases. PTP-MEG Antibodies are optimized for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).PTP-MEG, or protein tyrosine phosphatase-MEG, plays a crucial role in cellular signaling pathways by regulating the phosphorylation state of proteins, which is essential for controlling cell growth, differentiation, and metabolism. Dysregulation of PTP-MEG has been implicated in various diseases, including cancer and autoimmune disorders, making it a significant target for therapeutic intervention. Understanding PTP-MEG function is vital for advancing knowledge of cellular processes and developing potential treatments. Research has shown that PTP-MEG influences multiple signaling cascades that control cell fate decisions. Recent studies have highlighted PTP-MEG's involvement in immune system regulation and tumor suppression. Ongoing investigations continue to reveal new functions and regulatory mechanisms of PTP-MEG in different tissue types and developmental stages. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PTP-MEG's role in health and disease.